CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13

Allen C Gao, Wei Lou, Jin Tang Dong, John T. Isaacs

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

We have used microcell fusion-mediated chromosomal transfer to introduce normal human chromosomes into highly metastatic rodent prostatic cancer cells to map the location of a metastasis suppressor gene(s). Using this approach, several chromosomal regions have been identified that harbor such metastatic suppressor genes, including human chromosome 11 between p11.2-13 (T. Ichikawa el al., Cancer Res., 52: 3486-3490, 1992, 54: 2299-2302, 1994; N. Nihei el al., Genes Chromosomes and Cancer, 14: 112-119, 1995: C. W. Rinker-Schaeffer et al., Cancer Res., 54: 62496256, 1994). Using positional cloning, a metastatic suppressor gene, termed KAI1, was identified, which is located at human chromosome 11p11.2 (5). Overexpression of KAI1 results in metastasis suppression in certain highly metastatic Dunning R-3327 rat prostatic cancer sublines, such as AT6.1, without metastasis suppression in other highly metastatic sublines, such as AT3.1. This suggests that an additional metastasis suppressor gene in located within the human chromosome 11p11.2-13 region. The CD44 gene is located on human chromosome 11p13 and encodes an integral membrane glycoprotein that participates in specific cell-cell and cell-extracellular matrix interactions. Down-regulation of CD44 expression both at the mRNA and protein levels correlates with metastatic potential within the Dunning system of rat prostatic cancer sublines. Transfection- induced enhanced expression of the M(r) 85,000 standard form of CD44 in the highly metastatic AT3.1 rat prostatic cells greatly suppresses their metastatic ability to the lungs without suppression of their in vivo growth rate or tumorigenicity. These results suggest that CD44 is a metastasis suppressor for prostatic cancer and that decreased expression of the standard form of CD44 is involved in the progression of prostatic cancer in a metastatic state.

Original languageEnglish (US)
Pages (from-to)846-849
Number of pages4
JournalCancer Research
Volume57
Issue number5
StatePublished - 1997
Externally publishedYes

Fingerprint

Human Chromosomes
Tumor Suppressor Genes
Prostatic Neoplasms
Suppressor Genes
Neoplasm Metastasis
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 11
Neoplasm Genes
Membrane Glycoproteins
Extracellular Matrix
Transfection
Organism Cloning
Rodentia
Neoplasms
Down-Regulation
Lung
Messenger RNA
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. / Gao, Allen C; Lou, Wei; Dong, Jin Tang; Isaacs, John T.

In: Cancer Research, Vol. 57, No. 5, 1997, p. 846-849.

Research output: Contribution to journalArticle

Gao, Allen C ; Lou, Wei ; Dong, Jin Tang ; Isaacs, John T. / CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. In: Cancer Research. 1997 ; Vol. 57, No. 5. pp. 846-849.
@article{52647a638b334175937e6e721676cadd,
title = "CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13",
abstract = "We have used microcell fusion-mediated chromosomal transfer to introduce normal human chromosomes into highly metastatic rodent prostatic cancer cells to map the location of a metastasis suppressor gene(s). Using this approach, several chromosomal regions have been identified that harbor such metastatic suppressor genes, including human chromosome 11 between p11.2-13 (T. Ichikawa el al., Cancer Res., 52: 3486-3490, 1992, 54: 2299-2302, 1994; N. Nihei el al., Genes Chromosomes and Cancer, 14: 112-119, 1995: C. W. Rinker-Schaeffer et al., Cancer Res., 54: 62496256, 1994). Using positional cloning, a metastatic suppressor gene, termed KAI1, was identified, which is located at human chromosome 11p11.2 (5). Overexpression of KAI1 results in metastasis suppression in certain highly metastatic Dunning R-3327 rat prostatic cancer sublines, such as AT6.1, without metastasis suppression in other highly metastatic sublines, such as AT3.1. This suggests that an additional metastasis suppressor gene in located within the human chromosome 11p11.2-13 region. The CD44 gene is located on human chromosome 11p13 and encodes an integral membrane glycoprotein that participates in specific cell-cell and cell-extracellular matrix interactions. Down-regulation of CD44 expression both at the mRNA and protein levels correlates with metastatic potential within the Dunning system of rat prostatic cancer sublines. Transfection- induced enhanced expression of the M(r) 85,000 standard form of CD44 in the highly metastatic AT3.1 rat prostatic cells greatly suppresses their metastatic ability to the lungs without suppression of their in vivo growth rate or tumorigenicity. These results suggest that CD44 is a metastasis suppressor for prostatic cancer and that decreased expression of the standard form of CD44 is involved in the progression of prostatic cancer in a metastatic state.",
author = "Gao, {Allen C} and Wei Lou and Dong, {Jin Tang} and Isaacs, {John T.}",
year = "1997",
language = "English (US)",
volume = "57",
pages = "846--849",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13

AU - Gao, Allen C

AU - Lou, Wei

AU - Dong, Jin Tang

AU - Isaacs, John T.

PY - 1997

Y1 - 1997

N2 - We have used microcell fusion-mediated chromosomal transfer to introduce normal human chromosomes into highly metastatic rodent prostatic cancer cells to map the location of a metastasis suppressor gene(s). Using this approach, several chromosomal regions have been identified that harbor such metastatic suppressor genes, including human chromosome 11 between p11.2-13 (T. Ichikawa el al., Cancer Res., 52: 3486-3490, 1992, 54: 2299-2302, 1994; N. Nihei el al., Genes Chromosomes and Cancer, 14: 112-119, 1995: C. W. Rinker-Schaeffer et al., Cancer Res., 54: 62496256, 1994). Using positional cloning, a metastatic suppressor gene, termed KAI1, was identified, which is located at human chromosome 11p11.2 (5). Overexpression of KAI1 results in metastasis suppression in certain highly metastatic Dunning R-3327 rat prostatic cancer sublines, such as AT6.1, without metastasis suppression in other highly metastatic sublines, such as AT3.1. This suggests that an additional metastasis suppressor gene in located within the human chromosome 11p11.2-13 region. The CD44 gene is located on human chromosome 11p13 and encodes an integral membrane glycoprotein that participates in specific cell-cell and cell-extracellular matrix interactions. Down-regulation of CD44 expression both at the mRNA and protein levels correlates with metastatic potential within the Dunning system of rat prostatic cancer sublines. Transfection- induced enhanced expression of the M(r) 85,000 standard form of CD44 in the highly metastatic AT3.1 rat prostatic cells greatly suppresses their metastatic ability to the lungs without suppression of their in vivo growth rate or tumorigenicity. These results suggest that CD44 is a metastasis suppressor for prostatic cancer and that decreased expression of the standard form of CD44 is involved in the progression of prostatic cancer in a metastatic state.

AB - We have used microcell fusion-mediated chromosomal transfer to introduce normal human chromosomes into highly metastatic rodent prostatic cancer cells to map the location of a metastasis suppressor gene(s). Using this approach, several chromosomal regions have been identified that harbor such metastatic suppressor genes, including human chromosome 11 between p11.2-13 (T. Ichikawa el al., Cancer Res., 52: 3486-3490, 1992, 54: 2299-2302, 1994; N. Nihei el al., Genes Chromosomes and Cancer, 14: 112-119, 1995: C. W. Rinker-Schaeffer et al., Cancer Res., 54: 62496256, 1994). Using positional cloning, a metastatic suppressor gene, termed KAI1, was identified, which is located at human chromosome 11p11.2 (5). Overexpression of KAI1 results in metastasis suppression in certain highly metastatic Dunning R-3327 rat prostatic cancer sublines, such as AT6.1, without metastasis suppression in other highly metastatic sublines, such as AT3.1. This suggests that an additional metastasis suppressor gene in located within the human chromosome 11p11.2-13 region. The CD44 gene is located on human chromosome 11p13 and encodes an integral membrane glycoprotein that participates in specific cell-cell and cell-extracellular matrix interactions. Down-regulation of CD44 expression both at the mRNA and protein levels correlates with metastatic potential within the Dunning system of rat prostatic cancer sublines. Transfection- induced enhanced expression of the M(r) 85,000 standard form of CD44 in the highly metastatic AT3.1 rat prostatic cells greatly suppresses their metastatic ability to the lungs without suppression of their in vivo growth rate or tumorigenicity. These results suggest that CD44 is a metastasis suppressor for prostatic cancer and that decreased expression of the standard form of CD44 is involved in the progression of prostatic cancer in a metastatic state.

UR - http://www.scopus.com/inward/record.url?scp=0031019095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031019095&partnerID=8YFLogxK

M3 - Article

C2 - 9041184

AN - SCOPUS:0031019095

VL - 57

SP - 846

EP - 849

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -